Predicting Hemorrhagic Transformation of Acute Ischemic Stroke: Prospective Validation of the HeRS Score
- PMID: 26765425
- PMCID: PMC4718251
- DOI: 10.1097/MD.0000000000002430
Predicting Hemorrhagic Transformation of Acute Ischemic Stroke: Prospective Validation of the HeRS Score
Abstract
Hemorrhagic transformation (HT) increases the morbidity and mortality of ischemic stroke. Anticoagulation is often indicated in patients with atrial fibrillation, low ejection fraction, or mechanical valves who are hospitalized with acute stroke, but increases the risk of HT. Risk quantification would be useful. Prior studies have investigated risk of systemic hemorrhage in anticoagulated patients, but none looked specifically at HT. In our previously published work, age, infarct volume, and estimated glomerular filtration rate (eGFR) significantly predicted HT. We created the hemorrhage risk stratification (HeRS) score based on regression coefficients in multivariable modeling and now determine its validity in a prospectively followed inpatient cohort.A total of 241 consecutive patients presenting to 2 academic stroke centers with acute ischemic stroke and an indication for anticoagulation over a 2.75-year period were included. Neuroimaging was evaluated for infarct volume and HT. Hemorrhages were classified as symptomatic versus asymptomatic, and by severity. HeRS scores were calculated for each patient and compared to actual hemorrhage status using receiver operating curve analysis.Area under the curve (AUC) comparing predicted odds of hemorrhage (HeRS score) to actual hemorrhage status was 0.701. Serum glucose (P < 0.001), white blood cell count (P < 0.001), and warfarin use prior to admission (P = 0.002) were also associated with HT in the validation cohort. With these variables, AUC improved to 0.854. Anticoagulation did not significantly increase HT; but with higher intensity anticoagulation, hemorrhages were more likely to be symptomatic and more severe.The HeRS score is a valid predictor of HT in patients with ischemic stroke and indication for anticoagulation.
Conflict of interest statement
The authors have no funding and conflicts of interest to disclose.
Figures
Similar articles
-
Hemorrhagic transformation in patients with acute ischaemic stroke and an indication for anticoagulation.Eur J Neurol. 2013 Jun;20(6):962-7. doi: 10.1111/ene.12126. Epub 2013 Mar 21. Eur J Neurol. 2013. PMID: 23521544 Free PMC article.
-
Low glomerular filtration rate increases hemorrhagic transformation in acute ischemic stroke.Cerebrovasc Dis. 2013;35(1):53-9. doi: 10.1159/000345087. Epub 2013 Feb 14. Cerebrovasc Dis. 2013. PMID: 23428997
-
Hemorrhagic transformation of childhood arterial ischemic stroke.Stroke. 2011 Apr;42(4):941-6. doi: 10.1161/STROKEAHA.110.604199. Epub 2011 Feb 24. Stroke. 2011. PMID: 21350202 Free PMC article.
-
Safety of Intravenous Thrombolysis Among Patients Taking Direct Oral Anticoagulants: A Systematic Review and Meta-Analysis.Stroke. 2020 Feb;51(2):533-541. doi: 10.1161/STROKEAHA.119.026426. Epub 2019 Dec 30. Stroke. 2020. PMID: 31884908
-
Emergent use of anticoagulation for treatment of patients with ischemic stroke.Stroke. 2002 Mar;33(3):856-61. doi: 10.1161/hs0302.104628. Stroke. 2002. PMID: 11872915 Review.
Cited by
-
MRI-Based Predictors of Hemorrhagic Transformation in Patients With Stroke Treated by Intravenous Thrombolysis.Front Neurol. 2019 Aug 27;10:897. doi: 10.3389/fneur.2019.00897. eCollection 2019. Front Neurol. 2019. PMID: 31507511 Free PMC article.
-
The value of the CRP-albumin-lymphocyte index (CALLY index) as a prognostic biomarker in acute ischemic stroke.Sci Rep. 2025 Apr 21;15(1):13672. doi: 10.1038/s41598-025-97538-7. Sci Rep. 2025. PMID: 40258922 Free PMC article.
-
Therapies for Hemorrhagic Transformation in Acute Ischemic Stroke.Curr Treat Options Neurol. 2017 Jan;19(1):1. doi: 10.1007/s11940-017-0438-5. Curr Treat Options Neurol. 2017. PMID: 28130682 Review.
-
Prognostic Value of a New Integrated Parameter-Both Collateral Circulation and Permeability Surface-in Hemorrhagic Transformation of Middle Cerebral Artery Occlusion Acute Ischemic Stroke: Retrospective Cohort Study.Front Aging Neurosci. 2021 Aug 25;13:703734. doi: 10.3389/fnagi.2021.703734. eCollection 2021. Front Aging Neurosci. 2021. PMID: 34512306 Free PMC article.
-
Association Between Raised HbA1c Levels and Hemorrhagic Transformation in Patients With Ischemic Stroke.Cureus. 2021 Nov 27;13(11):e19935. doi: 10.7759/cureus.19935. eCollection 2021 Nov. Cureus. 2021. PMID: 34966619 Free PMC article.
References
-
- Jickling GC, Manolescu BN. Breaking down barriers to identifying hemorrhagic transformation in ischemic stroke. Neurology 2012; 79:1632–1633. - PubMed
-
- Khatri P, Wechsler LR, Broderick JP. Intracranial hemorrhage associated with revascularization therapies. Stroke 2007; 38:431–440. - PubMed
-
- Toni D, Fiorelli M, Bastianello S, et al. Hemorrhagic transformation of brain infarct: predictability in the first 5 hours from stroke onset and influence on clinical outcome. Neurology 1996; 46:341–345. - PubMed
-
- Hornig CR, Dorndorf W, Agnoli AL. Hemorrhagic cerebral infarction—a prospective study. Stroke 1986; 17:179–185. - PubMed
-
- Coull BM, Williams LS, Goldstein LB, et al. Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the joint stroke guideline development committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association). Stroke 2002; 33:1934–1942. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous